Evidence map›Paper›PMID 41408479›Full record

ArticleJournal of human genetics2026

Monoallelic and biallelic RNU4-2 variants in neurodevelopmental disorders.

Yukina Hayashi, Kenta Kajiwara, Seiji Mizuno, Nobuhiko Okamoto, Mei Yan Chan, Tomohide Goto, Seiichi Hayakawa, Mitsuhiro Kato, Chong Ae Kim, Dorit Lev and 26 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Yukina HayashiDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Kenta KajiwaraDepartment of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Seiji MizunoDepartment of Pediatrics and Genetics, Aichi Developmental Disability Center Central Hospital, Kasugai, Aichi, Japan.ORCID http://orcid.org/0000-0002-1491-4124
Nobuhiko OkamotoDepartment of Medical Genetics, Osaka Women's and Children's Hospital, Osaka, Japan.
Mei Yan ChanDepartment of Genetics, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia.
Tomohide GotoDepartment of Neurology, Kanagawa Children's Medical Center, Yokohama, Japan.
Seiichi HayakawaDepartment of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Mitsuhiro KatoDepartment of Pediatrics, Showa Medical University School of Medicine, Tokyo, Japan.
Chong Ae KimGenetics Unit, Instituto da Criança, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.
Dorit LevWolfson Medical Center, Holon, Israel.
Lip Hen MoeyDepartment of Clinical Genetics, Penang Hospital, Pulau Pinang, Malaysia.
Juliet TaylorGenetic Health Service NZ, Northern Hub, Auckland City Hospital, Auckland, New Zealand.
Nerine GregersenGenetic Health Service NZ, Northern Hub, Auckland City Hospital, Auckland, New Zealand.
Ifat Nezer-KanerWolfson Medical Center, Holon, Israel.
Wee Teik KengDepartment of Genetics, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia.
Satoshi OkadaDepartment of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.ORCID http://orcid.org/0000-0002-4622-5657
Hitoshi OsakaDepartment of Pediatrics, Jichi Medical School, Shimotsuke, Tochigi, Japan.ORCID http://orcid.org/0000-0002-1320-1165
Tally SagieWolfson Medical Center, Holon, Israel.
Yasunari SakaiDepartment of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.ORCID http://orcid.org/0000-0002-5747-8692
Katsuya TashiroDepartment of Pediatrics, Japanese Red Cross Karatsu Hospital, Karatsu, Saga, Japan.
Patrick YapGenetic Health Service NZ, Northern Hub, Auckland City Hospital, Auckland, New Zealand.ORCID http://orcid.org/0000-0002-4372-0580
Li FuDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Kazuhiro IwamaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Qiaowei LiangDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID http://orcid.org/0000-0002-5207-9588
Naoto NishimuraDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Suzuran SaitoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Masamune SakamotoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Yasuhiro UtsunoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID http://orcid.org/0000-0002-7889-0328
Naomi TsuchidaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID http://orcid.org/0000-0001-7203-884X
Yuri UchiyamaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID http://orcid.org/0000-0002-4540-5277
Eriko KoshimizuDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID http://orcid.org/0000-0001-9947-3315
Kohei HamanakaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID http://orcid.org/0000-0001-5179-331X
Satoko MiyatakeDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID http://orcid.org/0000-0001-7587-5168
Takeshi MizuguchiDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID http://orcid.org/0000-0003-4998-1244
Atsushi FujitaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID http://orcid.org/0000-0003-1572-1014
Naomichi MatsumotoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan. naomat@yokohama-cu.ac.jp.ORCID http://orcid.org/0000-0001-9846-6500

Funding

Japan Agency for Medical Research and Development (AMED) JP25ek0109674, JP25ek0109760, JP25ek0109617, JP25ek0109648, JP25ek0109677MEXT | Japan Society for the Promotion of Science (JSPS) JP21K07869MEXT | Japan Society for the Promotion of Science (JSPS) JP22K15901MEXT | Japan Society for the Promotion of Science (JSPS) JP23H02829MEXT | Japan Society for the Promotion of Science (JSPS) JP23H02877MEXT | Japan Society for the Promotion of Science (JSPS) JP23K07229MEXT | Japan Society for the Promotion of Science (JSPS) JP23K15353MEXT | Japan Society for the Promotion of Science (JSPS) JP24K02230
6 · The paper itself

Abstract

The accurate removal of intronic sequences from pre-mRNA by the spliceosome is essential for correct gene expression, with small nuclear RNAs (snRNAs) such as U4 playing structural and regulatory roles in catalyzing this. De novo variants in the highly constrained critical region including the T-loop region of RNU4-2 have been linked to ReNU syndrome, a neurodevelopmental disorder, but the broader mutational spectrum remains uncharacterized. Here, we show that, in a cohort of unresolved cases with neurodevelopmental disorder, monoallelic and biallelic RNU4-2 variants were identified in 16 affected individuals, expanding the genetic basis beyond the critical region: 12 with de novo T-loop variants and 4 from two families with compound heterozygous variants in non-critical regions (stem II, the k-turn, and the Sm-binding site). Previously reported functional mapping by saturation genome editing confirmed that most of the variant positions in this study are highly functionally constrained. Clinically, individuals with biallelic variants exhibited developmental delay and intellectual disability that were similar to but milder than those with monoallelic variants, notably lacking extracerebral organ involvement. These results suggest that pathogenic RNU4-2 variants act in both dominant and recessive manners, and that non-critical regions may also harbor disease-causing variants. More broadly, this study underscores the diagnostic importance of non-coding RNA genes in neurodevelopmental disorders and demonstrates the need to distinguish pathogenic variants from benign ones, together with their inheritance patterns.

Indexed as

Neurodevelopmental DisordersRNA, Small NuclearAdolescentAllelesChildChild, PreschoolDevelopmental DisabilitiesFemaleHumansInfantIntellectual DisabilityMaleMutationPedigreeRNA, Small Nuclear

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.